Table 2B.
SOLITARY EXTRAMEDULLARY PLASMACYTOMA
| Authors | N. | FU (m) | LC (%) | MMP (%) | OS (%) |
|---|---|---|---|---|---|
| Liebross et al, 1999 [13]. | 22 | / | 95 | 32 | 56 |
| Galieni et al, 2000 [7]. | 46 | 118 | 92 | 15 | 78 |
| Tsang et al, 2001 [37]. | 14 | 96 | 93 | 16 | / |
| Ozsahin et al, 2006 [38]. | 52 | 56 | 68 | 36 | 72 |
| Kilciksiz et al, 2008 [8]. | 23 | 28 | 95 | 7.4y | 89 |
| Suh et al, 2012 [42]. | 22 | 50 | 77 | 29 | 87 |
| Katodritou et al, 2014 [43]. | 32 | 60 | 69 | 21 | 89 |
| Li et al, 2015 [54]. | 22 | 55 | / | 6 | 94 (at 5y) |
| De Wall et al, 2016 [18]. | 50 | 89 | / | 12 | 77 |
| Finsinger et al, 2016 [27]. | 18 | 107 | / | 5 | 88 |
FU: follow-up. LC: Local Control. M: months. Y: years. MMP: multiple myeloma progression (at 10y). OS: overall survival (at 10y).